Baird analyst Ben Kallo maintains Tesla (NASDAQ:TSLA) with a Outperform and lowers the price target from $316 to $252.
Health Care Company Johnson & Johnson Announces Merger With Ambrx Biopharma
Johnson & Johnson (NYSE:JNJ) has announced a merger with Ambrx Biopharma (NASDAQ:AMAM) that is expected to be completed…